Impact of Front-of-package Warning Labels on Perceived Weight Stigmatization

February 9, 2024 updated by: University of North Carolina, Chapel Hill

Examining the Impact of Different Types of Front-of-package Warning Labels for Sugar-sweetened Beverages on Perceived Weight Stigmatization Among a Sample of US Adults

The goal of this experiment is to examine the effects of three different types of front-of-package warning labels for sugar-sweetened beverages on perceived weight stigmatization, as well as the effect of making such labels more weight-neutral. The main questions this experiment aims to answer are:

  • Are certain types of front-of-package warning labels perceived as more stigmatizing than others?
  • Are more weight-neutral versions of front-of-package warning labels perceived as less stigmatizing than their regular versions?
  • Is there a trade-off between label effectiveness in discouraging product consumption and perceived weight stigmatization?

Additionally, this experiment also aims to answer the following questions:

  • Does exposure to certain types of front-of-package warning labels lead to changes in participants' weight bias?
  • Are changes in participants' weight bias as a result of label exposure mediated by attribution of personal responsibility for body weight, pathogen disgust, or perceived social consensus?

Study Overview

Detailed Description

Participants will be randomly assigned to see one of four types of labels: control labels, nutrient warning labels, text-only health warning labels, or graphic health warning labels. Participants will then see an image depicting different types of fictional sugar-sweetened beverages carrying the label type that they were assigned to. Participants will see this image twice, in random order, each time differing in whether the label is weight-neutral or not (i.e., whether the label references calories/obesity or not). Each time, participants will answer survey questions about the label. Last, participants will answer survey questions measuring their weight bias and potential mediating variables.

Study Type

Interventional

Enrollment (Actual)

2522

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Chapel Hill, North Carolina, United States, 27516
        • University of North Carolina at Chapel Hill

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion criteria:

  • At least 21 years of age.
  • Residing in the US.

Exclusion Criteria:

-Involved in any pre-testing.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: Control labels
Individuals in this trial arm will see neutral control labels on sugar-sweetened beverages.

In random order, participants in this arm will see an image of fictional sugar-sweetened beverages carrying:

  • A neutral bar code label
  • A neutral quick response (QR) code label (not scannable)
Experimental: Nutrient warning labels
Individuals in this trial arm will see nutrient warning labels on sugar-sweetened beverages.

In random order, participants in this arm will see an image of fictional sugar-sweetened beverages carrying:

  • Labels that read "high in sugars" and "high in calories"
  • A label that reads "high in sugars"
Experimental: Text-only health warning labels
Individuals in this trial arm will see text-only health warning labels on sugar-sweetened beverages.

In random order, participants in this arm will see an image of fictional sugar-sweetened beverages carrying:

  • A label that reads "Drinking beverages with added sugars contributes to obesity, type 2 diabetes and tooth decay"
  • A label that reads "Drinking beverages with added sugars contributes type 2 diabetes and tooth decay"
Experimental: Graphic warning labels
Individuals in this trial arm will see graphic health warning labels on sugar-sweetened beverages.

In random order, participants in this arm will see an image of fictional sugar-sweetened beverages carrying:

  • A label that reads "Drinking beverages with added sugars contributes to obesity, type 2 diabetes and tooth decay" and contains graphics illustrating obesity, type 2 diabetes, and tooth decay
  • A label that reads "Drinking beverages with added sugars contributes type 2 diabetes and tooth decay" and contains graphics illustrating type 2 diabetes and tooth decay

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived weight stigmatization, mean score
Time Frame: Immediately after exposure to intervention (i.e., study stimuli), assessed during one-time online study survey.
Stigmatization of people with obesity will be measured by survey through a three-item scale. Items will inquire about how much participants perceive the label to (1) stigmatize people with obesity, (2) promote negative stereotypes about people with obesity, and (3) portray people with obesity in a disrespectful manner. Response options will be on a 1 to 5 scale, with higher scores representing a higher perceived weight stigmatization by the study labels. Each participant's responses to each item will be combined to obtain their final score on the outcome.
Immediately after exposure to intervention (i.e., study stimuli), assessed during one-time online study survey.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived message effectiveness, mean score
Time Frame: Immediately after exposure to intervention (i.e., study stimuli), assessed during one-time online study survey.
How much the labels discourage participants from wanting to consume the products will be measured by survey. Response options will be on a 1 to 5 scale, with higher scores representing a higher perceived message effectiveness.
Immediately after exposure to intervention (i.e., study stimuli), assessed during one-time online study survey.
Weight bias, mean score
Time Frame: Immediately after exposure to intervention (i.e., study stimuli), assessed during one-time online study survey.
Weight bias will be measured by survey through a seven-item scale. Items will present participants with adjective pairs and ask that they select the box closest to the adjective that they feel best describe their feelings and beliefs about people with obesity: (1) lazy-industrious, (2) no will power - has will power, (3) good self-control - poor self-control, (4) active - inactive, (5) self-indulgent - self-sacrificing, (6) dislikes food - likes food, (7) undereats - overeats. Response options will be 5 boxes between adjectives, which will be coded on a 1 to 5 scale so that higher scores represent higher weight bias. Each participant's responses to each item will be combined to obtain their final score on the outcome.
Immediately after exposure to intervention (i.e., study stimuli), assessed during one-time online study survey.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Aline D'Angelo Campos, MPP, University of North Carolina, Chapel Hill

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 18, 2024

Primary Completion (Actual)

January 26, 2024

Study Completion (Actual)

January 26, 2024

Study Registration Dates

First Submitted

December 11, 2023

First Submitted That Met QC Criteria

December 11, 2023

First Posted (Actual)

December 21, 2023

Study Record Updates

Last Update Posted (Estimated)

February 13, 2024

Last Update Submitted That Met QC Criteria

February 9, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 23-3069

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

A deidentified dataset and analytic code will be uploaded to a public repository upon publication of the study.

IPD Sharing Time Frame

Upon publication of the study.

IPD Sharing Access Criteria

No access criteria. The dataset and analytic code will be made publicly available at Open Science Framework.

IPD Sharing Supporting Information Type

  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Weight Stigma

Clinical Trials on Control labels

Subscribe